Press release
Meningococcal Vaccines Market has Gained a Significant Impetus in the Global Arena in Recent Years
Transparency Market Research (TMR) has recently published a report on the global meningococcal vaccines market, according to which the market is estimated to expand at a healthy CAGR of 12.40% during the period between 2014 and 2022.The research report, titled “Meningococcal Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022,” projects this market to rise from an overall value of US$1.5 bn in 2013 to US$4.4 bn by the end of the forecast period.Obtain Report Details @ http://www.transparencymarketresearch.com/meningococcal-vaccines-market.html
Meningococcal infections such as meningococcemia, meningococcal pneumonia, and Meningitis are caused by Neisseria meningitidis and carry a high risk of mortality if left untreated. However, these infections can be prevented by meningococcal vaccines. Various versions of these vaccines are 85% to 100% efficient against different types of meningococcus, resulting in a swift recovery from sepsis and meningitis.
The meningococcal vaccines market has gained a significant impetus in the global arena in recent years, thanks to the advancement of the medical and healthcare industry in emerging economies. The increasing concerns over the growing incidence of meningitis and sepsis have also fueled the demand for these vaccines significantly across the world, states the report.
The research report has evaluated the worldwide meningococcal vaccines market on the basis of the type of meningococcal vaccine and the geographical distribution of this market. Based on the type, the market has been segmented into conjugate vaccines, men b vaccines, combination vaccines, and polysaccharide vaccines. In terms of revenue, the conjugate vaccines segment is expected to dominate the global market for meningococcal vaccines in the coming years. During the forecast period, the segment is likely to rise at a CAGR of 11.10% and reach a value of US$3.1 bn by the end of it.
On the regional basis, the worldwide meningococcal vaccines market has been segmented into Asia Pacific, Europe, North America, and the Rest of the World. In 2013, North America held the leading position in this market. However, Asia Pacific is likely to emerge as the fastest growing regional market for meningococcal vaccines over the forecast period. The continual rise in the region’s population base and the increasing focus on preventive measures against meningococcal infections are the major factors driving the growth of this regional market, states the research report.
Make an Enquiry @ http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1666
The report also studies the competitive landscape of the global market for meningococcal vaccines by profiling the key companies operating in this market. Serum Institute of India Ltd., Sanofi SA, Pfizer Inc., Nuron Biotech Inc., JN-International Medical Corp., GlaxoSmithKline Plc, Biomed Pvt. Ltd., Novartis International AG, and Baxter International Inc. have been identified as the leading meningococcal vaccine producers in the global arena. Among these, Sanofi, GSK Plc, and Novartis International dominate the worldwide market with a collective share of approximately 90%, notes the market study.
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Meningococcal Vaccines Market has Gained a Significant Impetus in the Global Arena in Recent Years here
News-ID: 538666 • Views: …
More Releases from Transparency Market Research
North America Climbing Gym Market Set to Hit US$ 1.9 n by 2031 amid Rising Indoo …
The North America Climbing Gym Market has been experiencing strong growth over the past decade, fueled by rising participation in indoor sports, increasing interest in adventure-based fitness activities, and the expansion of climbing as a mainstream recreational pursuit. Indoor climbing has become particularly popular due to its accessibility, community-oriented environment, and year-round usability, unlike outdoor climbing which is seasonal and location-dependent.
The North America Climbing Gym Market has been expanding rapidly,…
Global Ophthalmic Sutures Market to Reach USD 1.3 Billion by 2034, Driven by Ris …
The global Ophthalmic Sutures Market is experiencing significant momentum as demand surges for improved ophthalmic surgical outcomes amid increasing incidences of ocular disorders worldwide. According to the latest industry assessment, the market, valued at US$ 629.0 million in 2023, is projected to expand at a CAGR of 6.5% between 2024 and 2034, ultimately reaching US$ 1.3 billion by 2034.
This comprehensive press release provides an in-depth examination of market size, trends,…
Global Ophthalmology PACS Market to Reach USD 359.8 Mn by 2034, Driven by Rising …
The global Ophthalmology PACS (Picture Archiving and Communication System) Market is poised for strong expansion over the next decade as the industry continues transitioning toward digital, AI-enabled ophthalmic imaging management solutions. According to recent market assessments, the global Ophthalmology PACS market valued at US$ 167.8 Mn in 2023 is projected to grow at a CAGR of 7.3% from 2024 to 2034, ultimately reaching US$ 359.8 Mn by the end of…
Global Ophthalmology Surgical Devices Market Set to Reach USD 12.1 Billion by 20 …
The global Ophthalmology Surgical Devices Market is poised for steady expansion, driven by rising demand for advanced surgical systems, increasing prevalence of cataracts and glaucoma, and accelerating adoption of minimally invasive techniques. The market was valued at US$ 8.1 billion in 2022 and is projected to reach US$ 12.1 billion by 2031, expanding at a CAGR of 4.7% from 2023 to 2031.
Unlock crucial data and key findings from our Report…
More Releases for Meningococcal
Impact Of Rising Healthcare Spending On Meningococcal Vaccines: An Emerging Driv …
The Meningococcal Vaccines Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Meningococcal Vaccines Market Size and Projected Growth Rate?
The market size for meningococcal vaccines has seen rapid expansion in the past few years. The market is forecasted to increase from $3.89 billion…
Meningococcal Vaccines Market: Combating Life-Threatening Infections
In recent years, the global Meningococcal Vaccines Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Meningococcal Vaccines Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including…
Meningococcal Vaccines Market
Meningococcal Vaccines Market 2022
The Meningococcal Vaccines Market is expected to grow on an unabashed note in the next decade. With a worldwide shortage of healthcare staff, the healthcare IT solutions comprising web-based staffing platforms are doing the rounds. The future scenario won't be any different. These platforms would show the gaps, i.e. actual dearth of healthcare personnel like nurse's doctors, technicians, lab workers, and clinicians, which would help the entire…
Meningococcal Vaccines Market Report Up to 2031
Visiongain has published a new report on Meningococcal Vaccines Market Report 2021-2031: Forecasts by Vaccine Type (Conjugate, Polysaccharide, Others), by End-user (Paediatric, Adult, Traveler), by Brand (Bexsero, Menactra, Menveo, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios.
Download Exclusive Sample of Report @ https://www.visiongain.com/report/meningococcal-vaccines-market-2021/#download_sampe_div
Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations…
Global Meningococcal Vaccines Market Research Report
This report studies the global Meningococcal Vaccines market status and forecast, categorizes the global Meningococcal Vaccines market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report GlaxoSmithKline JN-International Medical Novartis International Sanofi Pfizer Baxter International Geographically, this report studies the top producers and…
Meningococcal Vaccines Market Growth by 2028 | GlaxoSmithKline, Polysaccharide M …
Partnerships between the private sector and public institutions have been the chief agenda of global public health initiatives. The last few years have witnessed an increase in several private-public partnerships specifically focussing on vaccine provision in developing countries. Partnerships like the International Coordinating Group on Vaccine Provision for Epidemic Meningitis Control (ICG) help magnify the vaccine outreach to remote areas of the world with the maximum need. The governments of…
